DYNATRONICS CORP
DYNTQOTCHealthcare · Surgical & Medical Instruments & Apparatus · UT · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $27.4M | $32.5M | $40.6M | $44.3M | $47.8M | $53.4M |
| Operating income | −$2.5M | −$2.3M | −$4.9M | −$4.8M | −$3.8M | −$3.0M |
| Net income | −$10.9M | −$2.7M | −$5.0M | −$4.0M | $2.0M | −$3.4M |
| Total assets | $15.4M | $25.9M | $30.1M | $35.4M | $39.1M | $37.6M |
| Total liabilities | $12.2M | $11.8M | $13.2M | $13.7M | $13.6M | $17.7M |
| Equity | $3.3M | $14.2M | $16.9M | $21.7M | $25.5M | $19.9M |
| EPS (diluted) | $-1.43 | $-1.00 | $-1.46 | $-1.32 | — | — |
| Shares out. | 16.0M | 5.9M | 4.3M | 18.6M | 17.4M | 14.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −9.0%
- Net margin
- −39.8%
- Return on equity
- −334.2%
- Return on assets
- −70.6%
- Return on capital (ROCE)
- −34.1%
- Liabilities / assets
- 78.9%
- Debt / equity
- 3.73×
- Book value / share
- $0.20
- Revenue growth (YoY)
- −15.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -9.04distress
- Accruals / assets
- −72.6%clean
- Beneish M-Score
- -6.40normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 17, 2025
- NT 10-Kmissed a reporting deadline ↗Sep 26, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)Feb 17, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 160 | 53.3 | 0.0% |
| Apr 30, 2026 | 160 | 1.0 | 0.0% |
| Apr 15, 2026 | 160 | 1.0 | 0.0% |
| Mar 31, 2026 | 160 | 1.0 | 0.0% |
| Mar 13, 2026 | 160 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Debt acceleration / triggering event · Director / officer changeJan 12, 2026
- Shareholder voteDec 17, 2025
- Director / officer changeMay 9, 2025
- Director / officer changeApr 18, 2025
- Entered a material agreementApr 4, 2025
- Shareholder voteDec 9, 2024
- Director / officer changeSep 24, 2024
- Delisting / listing-standard notice · Regulation FD disclosureJun 28, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AFeb 17, 2026
- 8-KFORM 8-KJan 12, 2026
- 8-KFORM 8-KDec 17, 2025
- 10-QFORM 10-QNov 19, 2025
- NT 10-QFORM NT 10-QNov 17, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 30, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 30, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 30, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 30, 2025
- ARSFORM ARSOct 28, 2025
- DEFA14AFORM DEFA14AOct 28, 2025
- DEF 14AFORM DEF 14AOct 28, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 23, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 15, 2025
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESOct 15, 2025